PDI CEO: 'Acquisition Puts Us in the Diagnostic Sweet Spot' - Presented by: The Aol. On Network

PDI guided lower for the third quarter and full year, but CEO Nancy Lurker, says now is the time for investors to look at the company as it just made its first acquisition in the molecular diagnostic space, which has the potential for more growth and higher margins than PDI’s traditional core business and she is bullish on where the new vertical will take the company.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
GILD $ 97.44 11.01 ▼ 10.15%
ACHN $ 15.4299 1.22 ▲ 8.58%
RAD $ 6.785 0.02 ▲ 0.22%
PBR $ 7.18 0.07 ▲ 0.98%
BAC $ 17.605 0.02 ▼ 0.09%
PBR/A $ 7.41 0.07 ▲ 0.95%
FB $ 80.97 1.09 ▲ 1.36%
AAPL $ 112.30 0.52 ▲ 0.47%

As of 12/22/2014, 09:43 AM
More Most Active